Imunon Revenue, Growth & Competitor Profile

DBA CELSION CORPORATION

Company Profile & Annual Report for Imunon

Access the complete profile.

Imunon Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	339112 Surgical & Medical Instrument Manufacturing
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	997 Lenox Drive #100 Lawrenceville, NJ 08648

Note: Revenues for privately held companies are statistical evaluations.


Imunon's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Imunon's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Imunon is classified as operating in the Surgical & Medical Instrument Manufacturing industry, NAICS Code 339112.

Imunon Annual Revenue and Growth Rate

Imunon	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Imunon's revenues are gauged from an analysis of company filings.

Imunon's Income Statement (based on Industry Averages)

Imunon P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Imunon is developing and marketing. Imunon doesn't have any recent trademark applications, indicating Imunon is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
THERAPLAS Development of platform technology, namely, cancer immunotherapy, infectious disease, and gene therapy platforms for manufacturing therapeutics; Biological and biotechnology research; research and development in the pharmaceutical and biotechnology fields; scientific research and development with regard to the manufacture of pharmaceutical preparations; chemical and biological analysis; development of pharmaceutical preparations for treating cancer; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific and technological research in the fields of genetics, immunotherapy, vaccination, and oncology	03/08/2023
PLACCINE Development of platform technology, namely, cancer immunotherapy, infectious disease vaccines, and gene therapy platforms for manufacturing therapeutics and vaccines; Biological and biotechnology research; research and development in the pharmaceutical and biotechnology fields; scientific research and development with regard to the manufacture of pharmaceutical preparations; chemical and biological analysis; development of pharmaceutical preparations for treating cancer; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific and technological research in the fields of genetics, immunotherapy, vaccination, and oncology	03/08/2023
IMUNON Pharmaceutical preparations, namely, immunotherapies for the treatment of cancer and infectious diseases; biological preparations for the treatment of cancer and infectious diseases; vaccines; pharmaceutical preparations for the prevention and treatment of cancer; Biological preparations for the prevention and treatment of cancer; pharmaceutical and biological preparations for the treatment of immune system related diseases and disorders; therapeutic agents for promotion of cancer immunity, namely, therapeutic pharmaceuticals and vaccines for the treatment and prevention of cancer	09/20/2021

See all trademarks and details in the Full Report.

Market Share of Imunon's Largest Competitors

A competitive analysis shows these companies are in the same general field as Imunon, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
EMBECTA	Parsippany, NJ	100
STRUCTURE MEDICAL	Mooresville, NC	34
AUTOCAM MEDICAL DEVICES	Kentwood, MI	30
SCHARNBERG HOLDING	Des Moines, IA	26
SPECIALTY SURGICAL INSTRUMENTATION	Antioch, TN	24
MIDWEST INTERVENTIONAL SYSTEMS	Maple Grove, MN	19
VITA NEEDLE	Needham, MA	17
PYLANT MEDICAL	Grapevine, TX	17
MEDTEC	Orange City, IA	16

Nearby Competitors

These companies are similar in business line and location to Imunon. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
ANTARES PHARMA	Ewing, NJ	100
DAIGGER SCIENTIFIC	Trenton, NJ	28
IMUNON	Lawrenceville, NJ	25
BIOPLAST MANUFACTURING	Hamilton, NJ	20
MEDICAL INDICATORS	Hamilton, NJ	7

Future Competition: Imunon's Fastest Growing Competitors

These companies are in the same general field as Imunon and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)